FDA Grants Historic Approval to Filspari for Rare Kidney Disease FSGS WASHINGTON — In a watershed moment for nephrology, the U.S. Food and Drug Administration (FDA) has granted approval to Filspari, marking the first-ever approved pharmacological treatment for focal segmental glomerulosclerosis (FSGS). Developed by Travere Therapeutics, the medication represents a critical breakthrough for patients battling … Read more
New FDA Drug for Rare Disease: A First-Time Approval
FDA Approves Leucovorin for Cerebral Folate Deficiency, Following Autism Research Discussion In a landmark decision, the Food and Drug Administration (FDA) has granted approval for the use of leucovorin in treating cerebral folate deficiency, a rare genetic disorder. This approval arrives several months after FDA Commissioner Dr. Marty Makary publicly highlighted the potential of this … Read more
The landscape of genetic medicine has irrevocably shifted. Ty Sperle, a 19-year-old from British Columbia, isn’t just a patient; he’s a pioneer. He’s the first person demonstrably cured of a genetic disease – chronic granulomatous disease (CGD) – using “prime editing,” a next-generation gene-editing technology. This isn’t simply a medical success story; it’s a watershed … Read more